Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-19

Clinical Trial Update: Metformin as RenoProtector of Progressive Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating metformin as a RenoProtector for progressive chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Chronic Kidney Diseases | Phase 3 | Status: UNKNOWN